---
id: aan-epilepsy-2024
title: "AAN Practice Guideline: Treatment of New-Onset Epilepsy in Adults"
short_title: "New-Onset Epilepsy - Adults"
organization: American Academy of Neurology
country: United States
url: https://www.aan.com/Guidelines/Home/GuidelineDetail/1285
specialty: neurology
guideline_type: clinical-practice
evidence_system: aan-grade
conditions:
  - Epilepsy
  - Seizure Disorder
  - Focal Epilepsy
  - Generalized Epilepsy
tags:
  - epilepsy
  - seizures
  - antiseizure medications
  - ASM
publication_date: 2024-04-15
previous_version_date: 2018-04-23
status: current
supersedes: aan-epilepsy-2018
superseded_by: null
pdf_path: null
has_pdf: false
last_reviewed: 2025-01-01
---

## Scope

This guideline provides updated recommendations for the treatment of new-onset epilepsy in adults, including antiseizure medication selection.

## Key Recommendations

### When to Start Treatment
- Treatment recommended after two unprovoked seizures
- Consider after single seizure if high recurrence risk (EEG abnormalities, structural lesion, nocturnal seizure)
- Discuss risks/benefits with patient

### Focal-Onset Seizures
**Level A (Strong Evidence):**
- Lamotrigine
- Levetiracetam

**Level B:**
- Carbamazepine
- Oxcarbazepine
- Zonisamide

**Considerations:**
- Lamotrigine: Good tolerability, slow titration required
- Levetiracetam: Rapid titration, behavioral side effects
- Carbamazepine/oxcarbazepine: Drug interactions, hyponatremia

### Generalized-Onset Seizures
**Level A:**
- Lamotrigine (may exacerbate myoclonic seizures)
- Levetiracetam
- Valproate (highly effective but teratogenic)

**Level B:**
- Zonisamide
- Perampanel

**Avoid in Generalized Epilepsy:**
- Carbamazepine, oxcarbazepine, phenytoin (may worsen absence, myoclonus)

### Special Populations
**Women of Childbearing Potential:**
- Avoid valproate
- Lamotrigine and levetiracetam preferred
- Folic acid supplementation
- Pregnancy planning counseling

**Elderly:**
- Lower doses, slower titration
- Avoid strong enzyme inducers
- Levetiracetam, lamotrigine, lacosamide well-tolerated

### Monitoring
- Baseline and periodic labs as indicated per drug
- Assess seizure frequency, tolerability
- Drug levels if adherence concern or toxicity
- EEG and MRI at diagnosis
